Hematology/Oncology Pharmacy Association
Extended-Duration Prophylaxis With Letermovir May Reduce CMV Reactivation in HSCT
BOSTON—Extended-duration prophylactic therapy with letermovir (Prevymis, Merck) may reduce cytomegalovirus ...
APRIL 6, 2022
Can Anakinra Spare Tocilizumab in Management of CAR T-Cell CRS?
BOSTON—The scramble for tocilizumab (Actemra, Genentech) as a treatment for severe COVID-19 has created ...
APRIL 6, 2022
Challenges to Cancer Pain Management Are Multifactorial
In the 1980s, up to 70% of cancer patients reported pain. Thirty years later, cancer pain prevalence has not ...
JUNE 26, 2017
Load more